- Home
- HUIZ vs ENLV Comparison
HUIZ vs ENLV Comparison
Compare HUIZ & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- ENLV
- Stock Information
- Founded
- HUIZ 2006
- ENLV 2005
- Country
- HUIZ China
- ENLV Israel
- Employees
- HUIZ N/A
- ENLV N/A
- Industry
- HUIZ Specialty Insurers
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- ENLV Health Care
- Exchange
- HUIZ Nasdaq
- ENLV Nasdaq
- Market Cap
- HUIZ 29.4M
- ENLV 24.4M
- IPO Year
- HUIZ 2020
- ENLV 1995
- Fundamental
- Price
- HUIZ $3.78
- ENLV $1.00
- Analyst Decision
- HUIZ
- ENLV Strong Buy
- Analyst Count
- HUIZ 0
- ENLV 2
- Target Price
- HUIZ N/A
- ENLV $9.50
- AVG Volume (30 Days)
- HUIZ 17.0K
- ENLV 50.8K
- Earning Date
- HUIZ 03-19-2025
- ENLV 03-28-2025
- Dividend Yield
- HUIZ N/A
- ENLV N/A
- EPS Growth
- HUIZ N/A
- ENLV N/A
- EPS
- HUIZ 0.29
- ENLV N/A
- Revenue
- HUIZ $170,927,079.00
- ENLV N/A
- Revenue This Year
- HUIZ N/A
- ENLV N/A
- Revenue Next Year
- HUIZ $10.46
- ENLV N/A
- P/E Ratio
- HUIZ $13.14
- ENLV N/A
- Revenue Growth
- HUIZ N/A
- ENLV N/A
- 52 Week Low
- HUIZ $2.15
- ENLV $0.81
- 52 Week High
- HUIZ $10.58
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- HUIZ 65.34
- ENLV 32.92
- Support Level
- HUIZ $2.95
- ENLV $1.00
- Resistance Level
- HUIZ $3.30
- ENLV $1.09
- Average True Range (ATR)
- HUIZ 0.21
- ENLV 0.08
- MACD
- HUIZ 0.06
- ENLV -0.00
- Stochastic Oscillator
- HUIZ 98.91
- ENLV 12.50
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.